Literature DB >> 16455876

Shiga toxins present in the gut and in the polymorphonuclear leukocytes circulating in the blood of children with hemolytic-uremic syndrome.

Maurizio Brigotti1, Alfredo Caprioli, Alberto E Tozzi, Pier Luigi Tazzari, Francesca Ricci, Roberto Conte, Domenica Carnicelli, Maria Antonietta Procaccino, Fabio Minelli, Alfonso V S Ferretti, Fabio Paglialonga, Alberto Edefonti, Gianfranco Rizzoni.   

Abstract

Hemolytic-uremic syndrome, the main cause of acute renal failure in early childhood, is caused primarily by intestinal infections from some Escherichia coli strains that produce Shiga toxins. The toxins released in the gut are targeted to renal endothelium after binding to polymorphonuclear leukocytes. The presence of Shiga toxins in the feces and the circulating neutrophils of 20 children with hemolytic uremic syndrome was evaluated by the Vero cell cytotoxicity assay and flow cytometric analysis, respectively. The latter showed the presence of Shiga toxins on the polymorphonuclear leukocytes of 13 patients, 5 of whom had no other microbiologic or serologic evidence of infection by Shiga toxin-producing Escherichia coli. A positive relationship was observed between the amounts of Shiga toxins released in the intestinal lumen and those released in the bloodstream. The toxins were detectable on the neutrophils for a median period of 5 days after they were no longer detectable in stools. This investigation confirms that the immunodetection of Shiga toxins on neutrophils is a valuable tool for laboratory diagnosis of Shiga toxin-producing Escherichia coli infection in hemolytic-uremic syndrome and provides clues for further studies on the role of neutrophils in the pathogenesis of this syndrome.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16455876      PMCID: PMC1392687          DOI: 10.1128/JCM.44.2.313-317.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Inhibition of neutrophil apoptosis by verotoxin 2 derived from Escherichia coli O157:H7.

Authors:  J Liu; T Akahoshi; T Sasahana; H Kitasato; R Namai; T Sasaki; M Inoue; H Kondo
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

2.  Damage to nuclear DNA induced by Shiga toxin 1 and ricin in human endothelial cells.

Authors:  Maurizio Brigotti; Roberta Alfieri; Piero Sestili; Mara Bonelli; Pier Giorgio Petronini; Andrea Guidarelli; Luigi Barbieri; Fiorenzo Stirpe; Simonetta Sperti
Journal:  FASEB J       Date:  2002-03       Impact factor: 5.191

3.  Detection of verocytotoxin bound to circulating polymorphonuclear leukocytes of patients with hemolytic uremic syndrome.

Authors:  D Maroeska W M Te Loo; Victor W M VAN Hinsbergh; Lambertus P W J VAN DEN Heuvel; Leo A H Monnens
Journal:  J Am Soc Nephrol       Date:  2001-04       Impact factor: 10.121

4.  Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome.

Authors:  D M te Loo; L A Monnens; T J van Der Velden; M A Vermeer; F Preyers; P N Demacker; L P van Den Heuvel; V W van Hinsbergh
Journal:  Blood       Date:  2000-06-01       Impact factor: 22.113

5.  Risk factors for poor renal prognosis in children with hemolytic uremic syndrome.

Authors:  Alessandra Gianviti; Alberto E Tozzi; Laura De Petris; Alfredo Caprioli; Lucilla Ravà; Alberto Edefonti; Gianluigi Ardissino; Giovanni Montini; Graziella Zacchello; Alfonso Ferretti; Carmine Pecoraro; Tommaso De Palo; Angela Caringella; Maurizio Gaido; Rosanna Coppo; Francesco Perfumo; Nunzia Miglietti; Ilse Ratsche; Rosa Penza; Giovambattista Capasso; Silvio Maringhini; Salvatore Li Volti; Carmen Setzu; Marco Pennesi; Alberto Bettinelli; Leopoldo Peratoner; Ivana Pela; Elio Salvaggio; Giuliana Lama; Salvatore Maffei; Gianfranco Rizzoni
Journal:  Pediatr Nephrol       Date:  2003-10-31       Impact factor: 3.714

6.  Prolongation of functional life-span of neutrophils by recombinant verotoxin 2.

Authors:  Jiajia Liu; Tao He; Yanzheng He; Zhongjie Zhang; Tohru Akahoshi; Hirobumi Kondo; Sen Zhong
Journal:  Chin Med J (Engl)       Date:  2002-06       Impact factor: 2.628

7.  Flow cytometry detection of Shiga toxins in the blood from children with hemolytic uremic syndrome.

Authors:  Pier Luigi Tazzari; Francesca Ricci; Domenica Carnicelli; Alfredo Caprioli; Alberto E Tozzi; Gianfranco Rizzoni; Roberto Conte; Maurizio Brigotti
Journal:  Cytometry B Clin Cytom       Date:  2004-09       Impact factor: 3.058

8.  Haemolytic-uraemic syndrome: an analysis of prognostic features.

Authors:  R S Trompeter; R Schwartz; C Chantler; M J Dillon; G B Haycock; R Kay; T M Barratt
Journal:  Arch Dis Child       Date:  1983-02       Impact factor: 3.791

9.  Shiga toxin-producing Escherichia coli infections associated with hemolytic uremic syndrome, Italy, 1988-2000.

Authors:  Alberto E Tozzi; Alfredo Caprioli; Fabio Minelli; Alessandra Gianviti; Laura De Petris; Alberto Edefonti; Giovanni Montini; Alfonso Ferretti; Tommaso De Palo; Maurizio Gaido; Gianfranco Rizzoni
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

10.  The development of neutrophilic polymorphonuclear leukocytes in human bone marrow.

Authors:  D F Bainton; J L Ullyot; M G Farquhar
Journal:  J Exp Med       Date:  1971-10-01       Impact factor: 14.307

View more
  21 in total

1.  Change in conformation with reduction of alpha-helix content causes loss of neutrophil binding activity in fully cytotoxic Shiga toxin 1.

Authors:  Maurizio Brigotti; Domenica Carnicelli; Valentina Arfilli; Laura Rocchi; Francesca Ricci; Pasqualepaolo Pagliaro; Pier Luigi Tazzari; Antonio González Vara; Matteo Amelia; Francesco Manoli; Sandra Monti
Journal:  J Biol Chem       Date:  2011-08-08       Impact factor: 5.157

2.  Towards monitoring real-time cellular response using an integrated microfluidics-matrix assisted laser desorption ionisation/nanoelectrospray ionisation-ion mobility-mass spectrometry platform.

Authors:  J R Enders; C C Marasco; A Kole; B Nguyen; S Sevugarajan; K T Seale; J P Wikswo; J A McLean
Journal:  IET Syst Biol       Date:  2010-11       Impact factor: 1.615

3.  Neutral glycosphingolipids in human blood: a precise mass spectrometry analysis with special reference to lipoprotein-associated Shiga toxin receptors.

Authors:  Christian H Schweppe; Petra Hoffmann; Jerzy-Roch Nofer; Gottfried Pohlentz; Michael Mormann; Helge Karch; Alexander W Friedrich; Johannes Müthing
Journal:  J Lipid Res       Date:  2010-05-05       Impact factor: 5.922

4.  Shiga toxin glycosphingolipid receptors of Vero-B4 kidney epithelial cells and their membrane microdomain lipid environment.

Authors:  Daniel Steil; Catherine-Louise Schepers; Gottfried Pohlentz; Nadine Legros; Jana Runde; Hans-Ulrich Humpf; Helge Karch; Johannes Müthing
Journal:  J Lipid Res       Date:  2015-10-13       Impact factor: 5.922

Review 5.  Induction of apoptosis by Shiga toxins.

Authors:  Vernon L Tesh
Journal:  Future Microbiol       Date:  2010-03       Impact factor: 3.165

Review 6.  Thrombotic Microangiopathy and the Kidney.

Authors:  Vicky Brocklebank; Katrina M Wood; David Kavanagh
Journal:  Clin J Am Soc Nephrol       Date:  2017-10-17       Impact factor: 8.237

7.  Comparative analysis of the abilities of Shiga toxins 1 and 2 to bind to and influence neutrophil apoptosis.

Authors:  Michael J Flagler; Jane E Strasser; Claudia L Chalk; Alison A Weiss
Journal:  Infect Immun       Date:  2006-11-13       Impact factor: 3.441

Review 8.  Renal and neurological involvement in typical Shiga toxin-associated HUS.

Authors:  Howard Trachtman; Catherine Austin; Maria Lewinski; Rolf A K Stahl
Journal:  Nat Rev Nephrol       Date:  2012-09-18       Impact factor: 28.314

9.  Escherichia coli O157:H7 survives within human macrophages: global gene expression profile and involvement of the Shiga toxins.

Authors:  Katherine Poirier; Sébastien P Faucher; Maxime Béland; Roland Brousseau; Victor Gannon; Christine Martin; Josée Harel; France Daigle
Journal:  Infect Immun       Date:  2008-08-25       Impact factor: 3.441

10.  Enterohemorrhagic Escherichia coli specific enterohemolysin induced IL-1β in human macrophages and EHEC-induced IL-1β required activation of NLRP3 inflammasome.

Authors:  Xiaoai Zhang; Yuli Cheng; Yanwen Xiong; Changyun Ye; Han Zheng; Hui Sun; Hongqing Zhao; Zhihong Ren; Jianguo Xu
Journal:  PLoS One       Date:  2012-11-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.